ASH 2025 LBA BRUIN-CLL 313 Update: Pirtobrutinib vs Bendamustine/Rituximab in 1L CLL
Two Onc Docs
00:00
When to treat CLL
Kareen explains indications for treatment: symptoms, cytopenias, organ compromise, and bulky disease.
Play episode from 03:10
Transcript
